Alnylam Pharmaceuticals(ALNY)第一财季经过调整之后的业绩为每股亏损62美分，预期每股亏损66美分。

(via:sina)

标签：业绩,美分,Pharmaceuticals,AlnylamPharmaceuticals,Alnylam,ALNY